Exact FDA event identifier

Event 81351

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: October 18, 2018
Product types: Drug
Classifications: Class III
Statuses: Terminated
Recalling firm wording: Promise Pharmacy LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Prednisolone and Gatifloxacin Ophthalmic Solution, 1%/0.5%, 3 mL dropper bottle, Rx Only, 31818 US Hwy 19N, Palm Harbor, FL 34684

D-0239-2019

Recall number: D-0239-2019
Initiated: October 18, 2018
Classification: Class III
Status: Terminated
Recalling firm: Promise Pharmacy LLC
Quantity: N/A

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Presence of precipitate

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of precipitate

Code information

Lot#: 04092018@2, Exp 12/03/2018

Distribution pattern

U.S.A. Nationwide.